According to news headlines today, a new test has been developed to predict how long women with ovarian cancer are likely to survive.
While some of the headlines have been quite alarmist we do welcome any information that helps us build a better picture of ovarian cancer.
Our Chief Executive, Katherine Taylor, said: “There is a positive way to look at this story. Anything that helps us learn more about how ovarian cancer behaves, and what it is that means some women survive for longer, can be used to work toward a future in which no woman dies before her time.
“Let’s view this as a positive step towards personalised medicine while recognising that it’s still very much in the early stages of research and is unlikely to be used in clinics for some time yet.”